ID   Raji CD19 Knockout
AC   CVCL_YN94
SY   Raji CD19-/-
DR   cancercelllines; CVCL_YN94
DR   Wikidata; Q98128794
WW   https://www.sigmaaldrich.com/catalog/product/sigma/atg001
CC   Population: African; Nigerian.
CC   Knockout cell: Method=ZFN; HGNC; 1633; CD19.
CC   Sequence variation: Gene fusion; HGNC; 5477; IGH + HGNC; 7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg213Gln (c.638G>A); ClinVar=VCV000135359; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Tyr234His (c.700T>C); ClinVar=VCV000376691; Zygosity=Heterozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Bone, jaw, maxilla; UBERON=UBERON_0002397.
ST   Source(s): Sigma-Aldrich
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 13
ST   D16S539: 8,11
ST   D5S818: 10,13
ST   D7S820: 10
ST   TH01: 6,7
ST   TPOX: 8,13
ST   vWA: 16,19
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0511 ! Raji
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 12-03-20; Last updated: 05-10-23; Version: 10
//